Future Oncology is a premier peer-reviewed journal published by FUTURE MEDICINE LTD, dedicated to advancing research and innovation within the field of oncology. Established in 2005 and set to continue through 2024, this journal serves as an essential resource for researchers, healthcare professionals, and students engaged in cancer studies. With its emphasis on groundbreaking findings and multidisciplinary approaches, Future Oncology holds an esteemed reputation, reflected in its 2023 category quartiles ranking it in Q2 for Cancer Research and Q1 for Medicine (miscellaneous). The journal is indexed in Scopus, showcasing its rigorous content, with rankings in the 63rd percentile for Oncology and the 46th percentile for Cancer Research. Although it does not operate on an open-access model, its commitment to disseminating cutting-edge findings makes it an invaluable asset for those seeking to stay at the forefront of oncology research.Future Oncology strives to bridge the gap between laboratory and clinical research, fostering collaboration and appreciation for the complexities of cancer treatment.

ONCOLOGIST is a premier, open-access journal published by Oxford University Press, advancing the field of cancer research since its inception in 1996. With an impressive H-Index and a prestigious placement within the Q1 category in Cancer Research, Medicine, and Oncology for 2023, ONCOLOGIST stands at the forefront of oncological science, boasting a Scopus rank of #55 out of 404 in Medicine and #47 out of 230 in Cancer Research. This journal not only disseminates cutting-edge research but also aims to foster multidisciplinary approaches that are critical for addressing the complex challenges faced in cancer therapy and survivorship. Be part of a vibrant community as you explore impactful research articles that contribute to the global conversation on cancer. ONCOLOGIST is dedicated to providing an accessible platform for authors and readers alike, ensuring that high-quality research is available to all stakeholders in the fight against cancer.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

INTERNAL MEDICINE JOURNAL, published by Wiley, stands as a prominent platform in the field of internal medicine, reflecting the latest advancements and research across a broad spectrum of topics within the discipline. With an ISSN of 1444-0903 and an E-ISSN of 1445-5994, this journal caters to a global audience, primarily situated in the United Kingdom. As a testament to its scholarly impact, the journal holds a Q2 ranking in the Internal Medicine category for 2023, indicating its influence within the field, and ranks #82 out of 167 in Scopus, placing it within the 51st percentile. Covering a convergence of years from 2001 to 2024, the INTERNAL MEDICINE JOURNAL aims to disseminate high-quality research that advances clinical practice, with diverse open access options available for broader readership and engagement. This publication is essential for researchers, healthcare professionals, and students seeking to deepen their understanding of internal medicine and contribute to its ongoing evolution.

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

CHINESE MEDICAL JOURNAL, published by Lippincott Williams & Wilkins, is a distinguished platform within the field of medicine, providing a vital forum for the dissemination of innovative research and clinical findings since its inception in 1946. With its open access model established in 2000, the journal ensures that critical medical advancements and insights are accessible to a global audience, fostering collaboration and continuous learning among researchers, healthcare professionals, and students alike. The journal’s impressive Q1 ranking in Medicine (miscellaneous), alongside its remarkable Scopus rank of #40 out of 636 in General Medicine, underscores its influential presence in the medical community, promoting high-quality research that advances health outcomes. As it converges historical and contemporary research, the CHINESE MEDICAL JOURNAL plays an essential role in bridging academic inquiry with practical medical application, emphasizing its commitment to improving global healthcare through rigorous scholarship and excellence.

BRITISH JOURNAL OF HOSPITAL MEDICINE is a distinguished publication in the field of medicine, focusing primarily on the latest research, clinical practices, and advancements in hospital medicine. Published by MA HEALTHCARE LTD in the United Kingdom, this journal serves as a critical resource for healthcare professionals, researchers, and students alike, featuring insightful articles that bridge the gap between theory and practice. Holding a Q3 ranking in the miscellaneous medicine category and positioned within the top half of Scopus rankings, the journal underscores its commitment to high-quality, peer-reviewed content. With its inception dating back to 1996, the BRITISH JOURNAL OF HOSPITAL MEDICINE has evolved to include a broad spectrum of topics relevant to contemporary hospital settings, ensuring its readers are well-equipped with the knowledge necessary for improving patient care. Access options are tailored to modern readership, enhancing the visibility and dissemination of vital medical research.

JBJS Reviews is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the fields of Orthopedics, Sports Medicine, and Surgery. With an impactful presence in the medical community, the journal is recognized for its high-quality and peer-reviewed content that boasts an impressive ranking, including a Q1 quartile status in both Orthopedics and Surgery as of 2023. This esteemed publication is indexed in Scopus, achieving a rank of #115 out of 551 in Medicine Surgery and #88 out of 321 in Medicine Orthopedics and Sports Medicine. Since its inception in 2014, JBJS Reviews has served as a critical platform for advancing knowledge and fostering innovation, offering researchers, professionals, and students valuable insights into the latest advancements, evidence-based practices, and trends in the orthopedic field. Although not currently offering open access, JBJS Reviews remains a pivotal resource for those aiming to stay at the forefront of orthopedic and surgical excellence.

ACADEMIC EMERGENCY MEDICINE, published by Wiley, stands as a leading journal in the field of emergency medicine, distinguished by its impressive rankings, including Q1 categories in both Emergency Medicine and Miscellaneous Medicine. With an ISSN of 1069-6563 and an E-ISSN of 1553-2712, the journal covers a broad array of topics relevant to emergency medicine, advancing research from its inception in 1994 up to 2024. Ranked #8 out of 109 in its category, this journal sits in the 93rd percentile according to Scopus, underscoring its significance and influence within the academic community. Although it does not currently offer open access options, its rigorous peer-review process and comprehensive publication standards ensure that only the highest quality research reaches its readership. Aimed primarily at researchers, practitioners, and students in the field, ACADEMIC EMERGENCY MEDICINE serves as an essential resource for those seeking to enhance their understanding and practice of emergency care, making significant contributions to both theory and clinical applications in the field.

Danish Medical Journal, published by the esteemed Danish Medical Association, is a vital platform in the field of medicine, providing open access research that reflects the current advances and innovations within the medical community. With an E-ISSN of 2245-1919, this journal has established itself as a significant contributor to the discourse in general medicine, holding a commendable Q3 rank in Scopus for 2023 and placed in the 65th percentile among its peers. The journal aims to disseminate high-quality research from Denmark and beyond, fostering collaboration and dialogue across disciplines. Researchers, healthcare professionals, and students alike will find invaluable insights into contemporary medical issues and evidence-based practices within its pages. The journal, which has successfully converged its focus from 2012 to 2024, is committed to continuing its legacy of excellence and innovation in medical literature, ensuring that readers remain at the forefront of medical science.